VAC_53_2026 - LABORATORY TECHNICIAN
20 hours ago
Badalona
ppThe Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive bcancer research center /b dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth. /ppThe IJC is also part of the network of Excellence Research Centers of Catalonia b(CERCA) /b and was accredited as a bSevero Ochoa Center of Excellence /b by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer b(FCAECC) /b. Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute b(ISCIII) /b. /ppThe IJC’s main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting‑edge scientific and technological facilities, as well as complementary community services. The IJC has bsix locations integrated into reference hospitals /b: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings. /ppThe Josep Carreras Leukemia Research Institute is looking for a bLaboratory Technician /b in the Stem cell biology, developmental leukemia and immunotherapy group led by bDr. Pablo Menéndez /b. /ph3RESEARCH DESCRIPTION /h3pThe Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, led by Dr. Pablo Menendez, is interested in understanding the cellular origin, etiology and pathogenesis of childhood leukemia. We aim to ascertain the cell in which mutations occur and we strive to discover which cells are responsible for triggering relapses. Furthermore, we work to identify new therapeutic targets and develop more targeted, less toxic therapies. To achieve this, our laboratory uses various approaches, including genetic studies, epigenetic techniques and animal models, as well as adoptive cell immunotherapy tools. /ph3MAIN RESPONSIBILITIES /h3ulliSupport in the management and handling of the laboratory’s different mouse colonies. /liliSupport in in vivo experiments, including administration of substances through different routes, IVIS imaging, euthanasia, and sample collection and processing. /liliSupport in monitoring animal welfare. /liliSupport in the general management and organization of the laboratory. /liliSupport in tissue sample processing. /liliSupport in molecular and cell biology techniques. /li /ulh3WHAT WE NEED /h3ulliDegree or technical qualification in Biology, Human Nutrition, Pharmacy, Biotechnology or a related field. /liliAccredited Training Course for Laboratory Animal Personnel (Functions a–c: Care and Euthanasia) in rodents. /liliExperience with mouse models, especially in the context of handling of laboratory animals, colony management, and animal welfare monitoring. /liliExperience in substance administration through different routes will be considered an asset, including intraperitoneal, intravenous, subcutaneous, intratibial, intrahepatic, and oral gavage administration. /liliFluency in English will be considered a plus. /liliWillingness to learn and strong teamwork skills /liliPro‑active, responsible and well‑organized /liliGood interpersonal skills and ability to work with other team members /li /ulh3WHAT WE OFFER /h3ulliPermanent contract (Contrato indefinido por actividades científico‑técnicas (IACT)) La contratación es parte del proyecto “Inestabilidad cromosómica y patofisiología de las células iniciadoras de leucemia en la leucemia linfoblástica aguda pediátrica con aneuploidías.” referencia PID2022‑ OB‑I00 financiado por MCIN/AEI/ / y por FEDER, Una manera de hacer Europa. /liliFull‑time contract (39 working hours per week). /liliAn exciting and innovative research project. /liliMeasures to reconcile work and family life. /liliFlexible remuneration program (kindergarten and other measures). /liliThe opportunity to contribute to cutting‑edge research projects in molecular biology and translational research. /liliWork in a mixed basic and clinical research environment at the Josep Carreras Leukaemia Research Institute. /liliThe stimulating environment of the IJC and its scientific network. /li /ulh3DEADLINE /h3pPlease submit your application by July 22nd, 2026. /ppThe IJC is an equal‑opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics. /p /p #J-18808-Ljbffr
Waiters
Sales & Marketing
Chef & Cook
Retail
Salon & Beauty
Construction & Trades
Fast Food
Accounting & Finance
Animal Care
Art, Media, Design
Bar Staff
Barista
Child Care
Cleaning
Customer Service
Driver & Delivery
Education
Engineering
Entertainment
Events & Promotion
Fashion
Healthcare
Host & Hostess
Information Technology
Kitchen Porter
Legal
Management
Manufacturing
Office & Admin
Science
Security
Sports & Wellness
Warehouse
Writing & Editing
Other
